×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Featured
Want to learn more about Pharmacovigilance and Risk Management Strategies Conference? You've come to the right site!
Program Committee
-
Stella Blackburn, MD, MA, MSc, FFPM, FISPE, FRCP Strategy
Consultant, United Kingdom -
James Wabby, MHS Global Head, Regulatory Affairs, Emerging Technologies and Combination Products
AbbVie, United States -
Mariette Boerstoel-Streefland, MD, MBA, MS Senior Vice President, Worldwide Safety Officer
Bristol-Myers Squibb Company, United States -
E. Stewart Geary, MD Senior Vice President
Eisai Co., Ltd., Japan -
Elizabeth E. Garrard, PharmD Executive Vice President, Global Safety Operations
Clinipace Worldwide, United States -
Lisa Melanie Harinstein, PharmD Team Leader, Division of Pharmacovigilance, FDA
FDA, United States -
Stephen Knowles, MD, MRCP Chief Medical Officer
Halozyme Therapeutics, United States -
Robert L. Levin, MD Lead Medical Officer for Pharmacovigilance Strategy
FDA, United States -
Michael Richardson, MD, FFPM, FRCP Senior Vice President, WorldWide Patient Safety
Bristol-Myers Squibb, United Kingdom -
Annette Stemhagen, DrPH, PhD, FISPE Chief Science Officer
UBC, United States -
Mick Foy Director of Delivery
Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
Have an account?